FDA panel to vote on Pfizer booster shot

Published on 17 Sep 2021, 9:40
Pfizer is hoping it will get the stamp of approval from the FDA. The drug maker says a third dose given 6 months after the second dose boosts efficacy back up to 95 percent.

Subscribe to WCVB on YouTube now for more: bit.ly/1e8lAMZ

Get more Boston news: wcvb.com
Like us: facebook.com/wcvb5
Follow us: twitter.com/WCVB
Instagram: instagram.com/wcvb5